Works matching AU Kim, Min Hwan

Results: 77
    1
    2

    SKI‐G‐801, an AXL kinase inhibitor, blocks metastasis through inducing anti‐tumor immune responses and potentiates anti‐PD‐1 therapy in mouse cancer models.

    Published in:
    Clinical & Translational Immunology, 2022, v. 11, n. 1, p. 1, doi. 10.1002/cti2.1364
    By:
    • Synn, Chun‐Bong;
    • Kim, Sung Eun;
    • Lee, Hee Kyu;
    • Kim, Min‐Hwan;
    • Kim, Jae Hwan;
    • Lee, Ji Min;
    • Jo, Ha Ni;
    • Lee, Wongeun;
    • Kim, Dong Kwon;
    • Byeon, Youngseon;
    • Kim, Young Seob;
    • Yun, Mi Ran;
    • Park, Chae‐Won;
    • Yun, Jiyeon;
    • Lim, Sangbin;
    • Heo, Seong Gu;
    • Yang, San‐Duk;
    • Lee, Eun Ji;
    • Lee, Seul;
    • Choi, Hunmi
    Publication type:
    Article
    3
    4
    5
    6

    Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER-2-negative metastatic breast cancer.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03782-7
    By:
    • Park, Changhee;
    • Suh, Koung Jin;
    • Kim, Se Hyun;
    • Lee, Kyung-Hun;
    • Im, Seock-Ah;
    • Kim, Min Hwan;
    • Sohn, Joohyuk;
    • Jeong, Jae Ho;
    • Jung, Kyung Hae;
    • Lee, Kyoung Eun;
    • Park, Yeon Hee;
    • Kim, Hee-Jun;
    • Cho, Eun Kyung;
    • Choi, In Sil;
    • Noh, Seung-Jae;
    • Shin, Inkyung;
    • Cho, Dae-Yeon;
    • Kim, Jee Hyun
    Publication type:
    Article
    7
    8

    On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates.

    Published in:
    Breast Cancer Research, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13058-022-01601-4
    By:
    • Kim, Chang Gon;
    • Kim, Min Hwan;
    • Kim, Jee Hung;
    • Kim, Seul-Gi;
    • Kim, Gun Min;
    • Kim, Tae Yeong;
    • Ryu, Won-Ji;
    • Kim, Jee Ye;
    • Park, Hyung Seok;
    • Park, Seho;
    • Cho, Young Up;
    • Park, Byeong Woo;
    • Kim, Seung Il;
    • Jeong, Joon;
    • Sohn, Joohyuk
    Publication type:
    Article
    9
    10
    11

    Copy number aberrations in circulating tumor DNA enables prognosis prediction and molecular characterization of breast cancer.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 9, p. 1036, doi. 10.1093/jnci/djad080
    By:
    • Kim, Min Hwan;
    • Kim, Gun Min;
    • Ahn, Jin Mo;
    • Ryu, Won-Ji;
    • Kim, Seul-Gi;
    • Kim, Jee Hung;
    • Kim, Tae Yeong;
    • Han, Hyun Ju;
    • Kim, Jee Ye;
    • Park, Hyung Seok;
    • Park, Seho;
    • Park, Byeong Woo;
    • Kim, Seung Il;
    • Jeong, Joon;
    • Lee, Jieun;
    • Paik, Soonmyung;
    • Kim, Sangwoo;
    • Jung, Kyung Hae;
    • Cho, Eun Hae;
    • Sohn, Joohyuk
    Publication type:
    Article
    12
    13
    14

    Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37768-3
    By:
    • Bae, Mingyun;
    • Kim, Gyuhee;
    • Lee, Tae-Rim;
    • Ahn, Jin Mo;
    • Park, Hyunwook;
    • Park, Sook Ryun;
    • Song, Ki Byung;
    • Jun, Eunsung;
    • Oh, Dongryul;
    • Lee, Jeong-Won;
    • Park, Young Sik;
    • Song, Ki-Won;
    • Byeon, Jeong-Sik;
    • Kim, Bo Hyun;
    • Sohn, Joo Hyuk;
    • Kim, Min Hwan;
    • Kim, Gun Min;
    • Chie, Eui Kyu;
    • Kang, Hyun-Cheol;
    • Kong, Sun-Young
    Publication type:
    Article
    15
    16
    17
    18
    19

    Trastuzumab deruxtecan versus trastuzumab emtansine in Asian patients with HER2‐positive metastatic breast cancer.

    Published in:
    Cancer Science, 2024, v. 115, n. 9, p. 3079, doi. 10.1111/cas.16234
    By:
    • Iwata, Hiroji;
    • Xu, Binghe;
    • Kim, Sung‐Bae;
    • Chung, Wei‐Pang;
    • Park, Yeon Hee;
    • Kim, Min Hwan;
    • Tseng, Ling‐Ming;
    • Chung, Chi‐Feng;
    • Huang, Chiun‐Sheng;
    • Kim, Jee Hyun;
    • Chiu, Joanne Wing Yan;
    • Yamashita, Toshinari;
    • Li, Wei;
    • Egorov, Anton;
    • Nishijima, Soichiro;
    • Nakatani, Shunsuke;
    • Nishiyama, Yuji;
    • Sugihara, Masahiro;
    • Cortés, Javier;
    • Im, Seock‐Ah
    Publication type:
    Article
    20
    21
    22
    23
    24
    25

    A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15).

    Published in:
    Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359231225029
    By:
    • Baek, Sun Kyung;
    • Jeong, Jae-ho;
    • Jung, KyungHae;
    • Ahn, Hee Kyung;
    • Kim, Min Hwan;
    • Sohn, Joohyuk;
    • Park, In Hae;
    • Ahn, Jin Seok;
    • Lee, Dae-Won;
    • Im, Seock-Ah;
    • Sim, Sung Hoon;
    • Lee, Keun Seok;
    • Hyun Kim, Jee;
    • Shim, Hyun-Jeong;
    • Chae, Yeesoo;
    • Koh, Su-Jin;
    • Lee, Hyorak;
    • Lee, Jieun;
    • Byun, Jae-Ho;
    • Seol, Youngmi
    Publication type:
    Article
    26

    Data collection framework for electronic medical record-based real-world data to evaluate the effectiveness and safety of cancer drugs: a nationwide real-world study of the Korean Cancer Study Group.

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221132628
    By:
    • Han, Hye Sook;
    • Lee, Kyoung Eun;
    • Suh, Young Ju;
    • Jee, Hee-Jung;
    • Kim, Bum Jun;
    • Kim, Hyeong Su;
    • Lee, Keun-Wook;
    • Ryu, Min-Hee;
    • Baek, Sun Kyung;
    • Park, In Hae;
    • Ahn, Hee Kyung;
    • Jeong, Jae Ho;
    • Kim, Min Hwan;
    • Lee, Dae Hyung;
    • Kim, Siheon;
    • Moon, Hyemi;
    • Son, Serim;
    • Byun, Ji-Hye;
    • Kim, Dong Sook;
    • An, Hyonggin
    Publication type:
    Article
    27
    28
    29
    30

    Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.

    Published in:
    JAMA Network Open, 2023, v. 6, n. 11, p. e2342107, doi. 10.1001/jamanetworkopen.2023.42107
    By:
    • Takahashi, Masato;
    • Cortés, Javier;
    • Dent, Rebecca;
    • Pusztai, Lajos;
    • McArthur, Heather;
    • Kümmel, Sherko;
    • Denkert, Carsten;
    • Park, Yeon Hee;
    • Im, Seock-Ah;
    • Ahn, Jin-Hee;
    • Mukai, Hirofumi;
    • Huang, Chiun-Sheng;
    • Chen, Shin-Cheh;
    • Kim, Min Hwan;
    • Jia, Liyi;
    • Li, Xin Tong;
    • Tryfonidis, Konstantinos;
    • Karantza, Vassiliki;
    • Iwata, Hiroji;
    • Schmid, Peter
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK‐rearranged lung cancer.

    Published in:
    EMBO Molecular Medicine, 2019, v. 11, n. 12, p. N.PAG, doi. 10.15252/emmm.201910581
    By:
    • Yun, Mi Ran;
    • Choi, Hun Mi;
    • Lee, You Won;
    • Joo, Hyeong Seok;
    • Park, Chae Won;
    • Choi, Jae Woo;
    • Kim, Dong Hwi;
    • Kang, Han Na;
    • Pyo, Kyoung‐Ho;
    • Shin, Eun Joo;
    • Shim, Hyo Sup;
    • Soo, Ross A;
    • Yang, James Chih‐Hsin;
    • Lee, Sung Sook;
    • Chang, Hyun;
    • Kim, Min Hwan;
    • Hong, Min Hee;
    • Kim, Hye Ryun;
    • Cho, Byoung Chul
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50